(marketscreener.com) The Quantum Genomics Company announces that, as part of its merger project with Exactcure, French HealthTech developing artificial intelligence software to adapt medication intake to the profile of each individual, the transactions concerning the reduction of its share capital and the contribution of 100% of ExactCure's shares were...https://www.marketscreener.com/quote/stock/QUANTUM-GENOMICS-16253203/news/Quantum-Genomics-Quantum-Genomics-announces-that-it-has-obtained-the-approval-of-Shareholders-46524454/?utm_medium=RSS&utm_content=20240425
Quantum Genomics is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure.